FIELD: chemistry.
SUBSTANCE: invention relates to the use of an arglabin derivative of formula Id as an agent having selective cytotoxic action on duodenal adenocarcinoma HuTu 80 and cervical carcinoma M-HeLa.
EFFECT: effective cytotoxic action of the arglabin derivative of formula Id on duodenal adenocarcinoma HuTu 80 and cervical carcinoma M-HeLa, which can be used in the development of targeted anticancer drugs having minimal side effects.
1 cl, 2 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814738C1 |
ARGLABIN DERIVATIVES WITH SELECTIVE CYTOTOXIC EFFECTS | 2023 |
|
RU2805915C1 |
FLUORINE-CONTAINING BENZYLATED ISATINS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2802016C1 |
PHOSPHONIUM SALTS BASED ON ALANTOLACTONE, HAVING ANTI-TUMOUR ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2818095C1 |
FLUORINE-CONTAINING BENZYLATED ISATINS | 2023 |
|
RU2816105C1 |
REGULATORS-DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND THEIR USE | 2019 |
|
RU2797408C2 |
BROMINE-CONTAINING STERICALLY HINDERED PHENOLS WITH ANTICANCER ACTIVITY | 2023 |
|
RU2822270C1 |
PHOSPHONIUM SALTS BASED ON BETULINIC ACID GLYCOSIDES WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2803739C1 |
PHOSPHONIUM SALTS BASED ON BETULINIC ACID, WITH CYTOTOXIC ACTIVITY RELATED TO PROSTATIC ACINOUS CARCINOMA | 2018 |
|
RU2665922C1 |
NEW STERICALLY HINDERED PHENOLS CONTAINING BENZOFUROXAN FRAGMENTS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2796810C1 |
Authors
Dates
2024-02-28—Published
2023-09-01—Filed